cdPCR in Real-Time Oncology
Join us for an exciting Seminar on “cdPCR in Real-Time Oncology“, brought to you by Sciencewerke and Stilla Technologies.
About Stilla Technologies & the naica® system
Stilla Technologies is a Paris-based European Biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing a ground-breaking and flexible digital PCR (dPCR) solution: the naica® system.
The naica® system is an easy-to-use dPCR platform that harnesses cutting-edge microfluidic technology to integrate the dPCR workflow onto a single consumable chip, for a fast and simple workflow with more sensitivity while reducing time and saving precious sample.
It is now recognized as a reliable tool for rare alleles and rare mutations detection, also for genotyping, absolute quantification and copy number variation. It has also been successfully implemented in a wide variety of applications including cancer, liquid biopsy, cell and gene therapy, infection disease detection, GMO and environmental testing.
Speaker
Andrew Hoskins is an Application Scientist in charge of technical support for Stilla Technologies.
He graduated from the University of Virginia in 2017 with a B.S. in Biochemistry and continued his studies at Virginia Commonwealth University to receive a M.S. in Biochemistry in 2019. Andrew has been working with PCR based applications since 2018 and began working with digital PCR in 2021.
Click here to register for the Seminar today!
Hurry, slots are limited!
Keen to know more about Stilla’s ddPCR system? Simply reach out to us at [email protected] for a demo session at your convenience!